Pluristem: Second Patient With ‘Life-Saving’ Cells Died

Pluristem Therapeutics Inc. said a second of the three patients given the company’s experimental stem cells has died after Pluristem touted the treatments as “life-saving.”

To continue reading this article you must be a Bloomberg Professional Service Subscriber.